A breakthrough migraine is an attack that occurs despite preventive treatment. It does not automatically mean the preventive has failed. Migraine preventives aim to reduce frequency and burden, not guarantee zero attacks. The meaningful question is whether your pattern improved enough, over enough time, at the prescribed dose, with tolerable side effects.
Prevention is not the same as a cure
A treatment may be helping even when attacks still happen. Benefits can show up as:
- Fewer monthly migraine or headache days.
- Shorter attacks.
- Lower peak severity.
- Better response to prescribed rescue treatment.
- Fewer acute-medication days.
- Less missed work, school, caregiving, or social time.
If you measure only “Did I get another migraine?”, partial but valuable improvement disappears.
Four reasons an attack can break through
The treatment has not had a fair trial yet
Some oral preventives require gradual dose adjustment, and many preventive decisions are based on several weeks at an adequate, tolerated dose. Injectable treatments and Botox also have their own assessment windows. Use the timeframe your prescriber set for your specific treatment.
The baseline was never clearly measured
Without a four-week baseline, “better” is vulnerable to memory. A month with eight attacks followed by six may feel unchanged, while a month with four unusually severe attacks may feel worse despite a lower count.
The preventive helps one outcome more than another
Frequency may remain similar while severity or duration falls. Alternatively, headache days may decline while disability remains high. Both are reasons to review the full pattern.
Another factor changed
Illness, sleep disruption, hormonal timing, a new medicine, medication overuse, or a high-stress period can temporarily change attack burden. That does not prove the preventive stopped working.
The five-number review
Compare a baseline period with the most recent complete 28-day period:
| Measure | Baseline | Current | |---|---:|---:| | Headache days | | | | Migraine days | | | | Acute-medication days | | | | Average severity | | | | Hours or days of function lost | | |
The preventive treatment progress calculator calculates change in monthly headache days while keeping the start date and assessment window visible. It is an educational organizer, not a verdict on whether to continue or stop treatment.
Do not change the plan on your own
Do not stop, double, delay, or combine preventive medication because of a breakthrough attack unless your prescriber has told you to do so. Sudden changes can be unsafe for some drugs. Follow the prescribed acute-treatment plan and contact the prescriber if attacks sharply worsen, side effects are concerning, or you do not know what rescue options are safe.
Also count every acute-treatment day. Frequent use can complicate the picture; the medication-overuse headache checker can organize those days by medicine class for a clinician discussion.
Questions to bring to your appointment
- What outcome are we using to judge success?
- When did I reach the target dose or full treatment window?
- Is this enough time to assess this specific preventive?
- What is my rescue plan for breakthrough attacks?
- Could side effects, adherence, another medicine, or acute-medication frequency be affecting the result?
Frequently asked questions
How many breakthrough migraines are normal?
There is no universal number. It depends on baseline frequency, treatment goal, disability, and individual response. Compare trends rather than one difficult week.
Does one severe migraine mean the preventive stopped working?
No. One attack cannot establish treatment failure. A sustained change across complete monthly periods is more informative.
When should I call my clinician?
Contact them for a major pattern change, troubling side effects, uncertainty about rescue treatment, or worsening despite the agreed assessment period. Seek emergency care for sudden extreme pain or new neurological warning signs.
Sources
- Preventive Therapy of Migraine — Continuum, 2018
- Early treatment in migraine: an International Headache Society position statement — Cephalalgia, 2025
